D1/D5

Class

dopamine receptor partial agonist

D1 and D5 are closely related dopamine receptor subtypes that belong to the 'D1-like' family of G protein-coupled receptors, distinct from the D2-like family (D2, D3, D4) targeted by most classic antiparkinsonian and antipsychotic drugs. D1/D5 receptors are densely expressed in brain regions governing voluntary movement, motivation, and cognition, and their activation stimulates intracellular signaling that promotes neuronal excitability. In Parkinson's disease, progressive loss of dopamine-producing neurons deprives these receptors of their natural ligand, contributing to motor symptoms such as slowness and rigidity. Rather than replacing dopamine broadly or fully activating D1/D5 receptors, a partial agonist binds the receptor and produces a submaximal, more controlled level of activation regardless of how much natural dopamine is also present. This can provide a steadier, dose-limited stimulation intended to support movement-related circuits while reducing the risk of overstimulation-related side effects that can occur with therapies producing very high receptor activity. This class of mechanism is studied primarily in movement disorders, particularly Parkinson's disease, and more broadly in neuropsychiatric conditions where dopaminergic tone is disrupted. Because D1/D5 signaling also intersects with reward and cognitive circuitry, modulating these receptors has relevance beyond motor control alone.